Literature DB >> 34098922

Association between body mass index and patient-reported-outcome questionnaire scores (CAT™, ACT™, mMRC dyspnoea scale, IPAQ) in Ukraine, Kazakhstan and Azerbaijan: results of the CORE study.

D Nugmanova1, Y Feshchenko2, L Iashyna2, M Polianska2, K Malynovska3, I Stafeyeva1, J Makarova4, A Vasylyev5.   

Abstract

BACKGROUND: The overweight/obese population (evaluated by a body mass index, BMI) represents a global health problem and contributes to the development of various chronic diseases. In this epidemiological study we evaluated this relationship by analyzing patient-reported questionnaires related to respiratory function, physical activity and BMI.
METHODS: In 2013-2015, adult residents of selected cities were enrolled to this study in: Ukraine (M/F: 403/561), Kazakhstan (M/F = 348/597) and Azerbaijan (M/F: 389/544). Height was measured using a vertical measuring board, and body weight was measured by using portable digital scales. All participants were interviewed using CAT™, mMRC scale and IPAQ; respondents who also reported wheezing or whistling chest sounds during the previous 12 months additionally ACT™.
RESULTS: 45.4% of respondents in Ukraine, 47.6% in Kazakhstan and 54.9% of respondents in Azerbaijan were found to be overweight/obese (BMI ≥ 25 kg/m2). The mean CAT™ total score among this population versus those respondents with a normal weight was 5.2 versus 3.6 (Ukraine, p < 0.001), 4.2 versus 2.9 (Kazakhstan, p < 0.001) and 5.9 versus 4.3 (Azerbaijan, p < 0.001). The number of respondents without airflow limitations (mMRC score 0) among overweight/obese respondents versus normal weight respondents was 298 (68.2%) versus 456 (86.7%) in Ukraine, 261 (58.1%) versus 387 (78.2%) in Kazakhstan and 343 (67.1%) versus 345 (82.3%) in Azerbaijan. The ACT™ total score between overweight/obese respondents and normal weight respondents was not statistically different. IPAQ showed a tendency towards a higher proportion of "low activity" results (compared to "moderate" and "high") in the overweight/obese subgroup (24.7% vs. 23.8% in Kazakhstan, 18.5% vs. 14.6% in Azerbaijan), and in Ukraine this difference was significant (12.4% vs. 5.2%, p < 0.001).
CONCLUSION: CAT™ and mMRC are widely used tools for respiratory function assessment. Despite CAT™ scores being close to a normal value (< 5), the relationship of both CAT™ and mMRC scores with being overweight/obese was demonstrated in the general adult population of three CIS countries. IPAQ may also be a useful instrument for measuring activity level however, more objective studies are required to evaluate the relationship between BMI and physical activity.

Entities:  

Keywords:  Asthma control test™; Azerbaijan; Body mass index; COPD assessment test™; International physical activity questionnaire; Kazakhstan; Modified medical research council dyspnoea; Ukraine

Year:  2021        PMID: 34098922     DOI: 10.1186/s12890-021-01542-2

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  18 in total

1.  Overweight and obesity are risk factors for COPD misdiagnosis and overtreatment.

Authors:  Frits M E Franssen
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

2.  Obesity and respiratory diseases.

Authors:  Christopher Zammit; Helen Liddicoat; Ian Moonsie; Himender Makker
Journal:  Int J Gen Med       Date:  2010-10-20

Review 3.  Obesity and the lung: 1. Epidemiology.

Authors:  K M McClean; F Kee; I S Young; J S Elborn
Journal:  Thorax       Date:  2008-07       Impact factor: 9.139

Review 4.  Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients.

Authors:  V Bellia; F Pistelli; D Giannini; N Scichilone; F Catalano; M Spatafora; R Hopps; L Carrozzi; S Baldacci; F Di Pede; P Paggiaro; G Viegi
Journal:  Eur Respir J Suppl       Date:  2003-05

5.  Lung function impairment and metabolic syndrome: the critical role of abdominal obesity.

Authors:  Nathalie Leone; Dominique Courbon; Frédérique Thomas; Kathy Bean; Bertrand Jégo; Bénédicte Leynaert; Louis Guize; Mahmoud Zureik
Journal:  Am J Respir Crit Care Med       Date:  2009-01-08       Impact factor: 21.405

Review 6.  Respiratory physiology and pulmonary complications in obesity.

Authors:  Justin C Sebastian
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-05-15       Impact factor: 4.690

7.  Prediction of risk of COPD exacerbations by the BODE index.

Authors:  Jose M Marin; Santiago J Carrizo; Ciro Casanova; Pablo Martinez-Camblor; Joan B Soriano; Alvar G N Agusti; Bartolome R Celli
Journal:  Respir Med       Date:  2008-11-17       Impact factor: 3.415

Review 8.  Obesity and respiratory diseases.

Authors:  A T Murugan; G Sharma
Journal:  Chron Respir Dis       Date:  2008       Impact factor: 2.444

9.  The prevalence, burden and risk factors associated with bronchial asthma in commonwealth of independent states countries (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study.

Authors:  Damilya Nugmanova; Lyudmila Sokolova; Yuriy Feshchenko; Liudmila Iashyna; Olga Gyrina; Katerina Malynovska; Ilgar Mustafayev; Gulzar Aliyeva; Janina Makarova; Averyan Vasylyev; Luqman Tariq
Journal:  BMC Pulm Med       Date:  2018-07-05       Impact factor: 3.317

10.  Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the commonwealth of independent states: rationale and design of the CORE study.

Authors:  Yuriy Feshchenko; Liudmyla Iashyna; Damilya Nugmanova; Olga Gyrina; Maryna Polianska; Alexander Markov; Maryna Moibenko; Janina Makarova; Luqman Tariq; Marcelo Horacio S Pereira; Eljan Mammadbayov; Irada Akhundova; Averyan Vasylyev
Journal:  BMC Pulm Med       Date:  2017-10-10       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.